tradingkey.logo

Bright Minds Biosciences Inc

DRUG

34.000USD

+0.370+1.10%
Market hours ETQuotes delayed by 15 min
240.83MMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-201.24%-2.43M
-81.78%-1.49M
61.32%-463.17K
114.55%240.16K
46.77%-805.09K
69.14%-822.09K
43.74%-1.20M
42.33%-1.65M
58.51%-1.51M
46.20%-2.66M
10.92%-2.13M
3.72%-2.86M
-159.01%-3.65M
-800.97%-4.95M
---2.39M
---2.97M
---1.41M
-819.96%-549.52K
---59.73K
Net income from continuing operations
-413.88%-2.95M
102.95%49.61K
49.38%-773.44K
115.77%229.90K
72.00%-574.14K
27.88%-1.68M
48.40%-1.53M
45.14%-1.46M
54.31%-2.05M
51.93%-2.34M
-3.28%-2.96M
24.77%-2.66M
-183.43%-4.49M
-628.28%-4.86M
---2.87M
---3.53M
---1.58M
-2023.57%-667.06K
---31.41K
Operating gains losses
24.12%22.48K
18.88%21.53K
5.01%19.02K
0.00%18.11K
-0.01%18.11K
0.01%18.11K
125.36%18.11K
--18.11K
--18.11K
--18.11K
--8.04K
----
----
----
----
----
----
----
----
Other non-cash items
443.28%11.76K
-3953.47%-1.63M
-109.17%-14.98K
69.64%-39.60K
-59.39%2.17K
500.01%42.30K
307.65%163.44K
-3150.50%-130.47K
-23.72%5.33K
103.68%7.05K
48.32%-78.71K
-98.54%4.28K
161.84%6.99K
-1367.44%-191.38K
---152.29K
--293.25K
---11.30K
--15.10K
----
Change in working capital
71.12%-138.63K
-120.45%-118.56K
136.57%93.39K
52.35%-153.43K
-200.16%-479.99K
168.74%579.85K
-130.26%-255.36K
35.77%-322.00K
-11.94%479.25K
-419.24%-843.60K
233.34%843.75K
-7621.08%-501.36K
779.54%544.20K
-943.21%-162.47K
--253.12K
--6.67K
--61.87K
45.01%-15.57K
---28.32K
-Change in receivables
67.23%-166.55K
-108.43%-16.80K
-149.46%-32.99K
862.32%536.01K
-2061.29%-508.21K
-108.35%-8.06K
173.02%66.69K
-162.80%-70.31K
197.00%25.91K
344.04%96.50K
-184.01%-91.34K
371.52%111.97K
26.30%-26.71K
-7808.80%-39.54K
---32.16K
---41.24K
---36.25K
---500.00
----
-Change in prepaid expenses
-955.94%-143.44K
-843.64%-41.32K
-238.82%-158.31K
-215.89%-43.00K
181.02%16.76K
-169.82%-4.38K
235.54%114.04K
662.24%37.11K
-136.29%-20.68K
-75.93%6.27K
-109.65%-84.14K
-96.10%4.87K
129.50%57.00K
39.23%26.05K
---40.13K
--124.73K
---193.23K
--18.71K
--0.00
-Change in payables and accrued expense
1395.54%171.36K
-110.20%-60.44K
165.28%284.69K
-123.84%-646.44K
-97.58%11.46K
162.58%592.29K
-142.79%-436.10K
53.28%-288.80K
-7.76%474.02K
-535.25%-946.38K
213.21%1.02M
-704.66%-618.19K
76.39%513.92K
-340.96%-148.98K
--325.41K
---76.83K
--291.35K
-19.29%-33.78K
---28.32K
Cash from non-recurring investing activities
Cash from operating activities
-201.24%-2.43M
-81.78%-1.49M
61.32%-463.17K
114.55%240.16K
46.77%-805.09K
69.14%-822.09K
43.74%-1.20M
42.33%-1.65M
58.51%-1.51M
46.20%-2.66M
10.92%-2.13M
3.72%-2.86M
-159.01%-3.65M
-800.97%-4.95M
---2.39M
---2.97M
---1.41M
-819.96%-549.52K
---59.73K
Investing cash flow
Cash from non-current investing activities
Net cash flow from investing activities
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
----
----
--22.88K
---22.88K
----
Financing cash flow
Cash flow from continuous financing activities
1126.47%225.38K
5826.92%52.04M
-8.83%-23.56K
-2.18%-21.96K
-2.17%-21.96K
-61.05%878.04K
-100.43%-21.64K
-279.07%-21.49K
-1376.13%-21.49K
1806.39%2.25M
52308.82%5.06M
102.20%12.00K
-99.99%1.68K
-93.76%118.25K
---9.70K
---545.55K
--24.71M
--1.90M
--0.00
Net cash flow from debt Issuance/repayment
-12.17%-24.63K
-8.35%-23.79K
-10.23%-23.86K
-2.18%-21.96K
-2.17%-21.96K
-2.18%-21.96K
-202.22%-21.64K
---21.49K
---21.49K
---21.49K
---7.16K
----
----
----
----
----
----
----
----
Net cash flow from common stock issuance/repurchase
--0.00
5303.22%48.63M
--0.00
--0.00
--0.00
-26.08%900.00K
-100.00%0.00
--0.00
--0.00
--1.22M
--4.03M
100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
---39.25K
--25.91M
--1.87M
--0.00
Proceeds from stock option exercised by employees
--250.01K
--930.09K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Proceeds from issuance of warrants
--0.00
--2.59M
--302.00
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
--0.00
817.78%1.09M
--1.84M
-86.27%12.00K
-100.00%0.00
--118.25K
--0.00
--87.40K
--10.00K
----
----
Net cash flow from other financing activities
--0.00
---83.72K
--0.00
----
----
100.00%0.00
100.00%0.00
--0.00
-100.00%0.00
---26.98K
-8164.57%-801.66K
100.00%0.00
100.14%1.68K
-100.00%0.00
---9.70K
---593.70K
---1.21M
--22.88K
----
Net cash from non-recurrent financing activities
Net cash from financing activities
1126.47%225.38K
5826.92%52.04M
-8.83%-23.56K
-2.18%-21.96K
-2.17%-21.96K
-61.05%878.04K
-100.43%-21.64K
-279.07%-21.49K
-1376.13%-21.49K
1806.39%2.25M
52308.82%5.06M
102.20%12.00K
-99.99%1.68K
-93.76%118.25K
---9.70K
---545.55K
--24.71M
--1.90M
--0.00
Net cash flow
Beginning cash balance
756.25%57.90M
-15.23%5.72M
-23.86%6.19M
-38.66%5.93M
-39.69%6.76M
-41.97%6.75M
-5.90%8.13M
-15.66%9.67M
-25.84%11.21M
-41.15%11.63M
-60.74%8.64M
-54.94%11.47M
616.87%15.12M
2370.22%19.76M
--22.01M
--25.45M
--2.11M
900.02%799.93K
--79.99K
Current period cash flow changes
-167.33%-2.22M
381838.17%52.18M
66.00%-470.15K
116.72%257.81K
46.13%-829.21K
103.28%13.66K
-146.29%-1.38M
45.47%-1.54M
57.84%-1.54M
91.03%-416.41K
232.94%2.99M
17.89%-2.83M
-115.64%-3.65M
-454.56%-4.64M
---2.25M
---3.44M
--23.34M
2291.50%1.31M
---59.73K
Effect of exchange rate changes
-678.29%-16.85K
3954.03%1.63M
110.14%16.57K
-69.64%39.60K
59.39%-2.17K
-500.01%-42.30K
-417.62%-163.44K
467.93%130.47K
23.72%-5.33K
-103.68%-7.05K
-66.21%51.46K
-69.49%22.97K
-161.84%-6.99K
1367.44%191.38K
--152.29K
--75.30K
--11.30K
---15.10K
----
Ending cash balance
838.57%55.68M
756.25%57.90M
-15.23%5.72M
-23.86%6.19M
-38.66%5.93M
-39.69%6.76M
-41.97%6.75M
-5.90%8.13M
-15.66%9.67M
-25.84%11.21M
-41.15%11.63M
-60.74%8.64M
-54.94%11.47M
616.87%15.12M
--19.76M
--22.01M
--25.45M
10310.60%2.11M
--20.26K
Free cash flow
----
----
----
----
----
----
----
----
----
----
----
----
----
-800.97%-4.95M
----
----
---1.41M
---549.52K
----
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
KeyAI